317 related articles for article (PubMed ID: 33392895)
1. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
[TBL] [Abstract][Full Text] [Related]
2. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
Obata S; Saishin Y; Teramura K; Ohji M
Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
[TBL] [Abstract][Full Text] [Related]
4. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
[No Abstract] [Full Text] [Related]
5. VOGT-KOYANAGI-HARADA-LIKE UVEITIS FOLLOWED BY MELANOMA-ASSOCIATED RETINOPATHY WITH FOCAL CHORIORETINAL ATROPHY AND CHOROIDAL NEOVASCULARIZATION IN A PATIENT WITH METASTATIC CUTANEOUS MELANOMA.
Ng CC; Alsberge JB; Qian Y; Freund KB; Cunningham ET
Retin Cases Brief Rep; 2023 Jan; 17(1):18-22. PubMed ID: 33394953
[TBL] [Abstract][Full Text] [Related]
6. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Ipilimumab-induced Multisystem Autoimmune-like Toxicities Suggestive of Vogt-Koyanagi-Harada-like Syndrome.
Monferrer-Adsuara C; Hernández-Bel L; Hernández-Garfella ML; Remolí-Sargues L; Ortiz-Salvador M; Castro-Navarro V; Cervera-Taulet E
Optom Vis Sci; 2021 Nov; 98(11):1309-1316. PubMed ID: 34510146
[TBL] [Abstract][Full Text] [Related]
8. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY.
Madoe A; Schauwvlieghe PP; Jacob J
Retin Cases Brief Rep; 2023 Sep; 17(5):611-615. PubMed ID: 37643052
[TBL] [Abstract][Full Text] [Related]
9. Vogt-Koyanagi-Harada disease-like uveitis induced by vemurafenib for metastatic cutaneous malignant melanoma.
Fusumae T; Kamiya K; Maekawa T; Komine M; Murata S; Inoda S; Takahashi R; Kawashima H; Ohtsuki M
J Dermatol; 2018 Jun; 45(6):e159-e160. PubMed ID: 29314171
[No Abstract] [Full Text] [Related]
10. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
11. A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy.
Minami K; Egawa M; Kajita K; Murao F; Mitamura Y
Case Rep Ophthalmol; 2021; 12(3):952-960. PubMed ID: 35082654
[TBL] [Abstract][Full Text] [Related]
12. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM
Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
Park HS; Nam KY; Kim JY
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
[TBL] [Abstract][Full Text] [Related]
14. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
Fukutsu K; Namba K; Iwata D; Mizuuchi K; Kase S; Suzuki K; Shimizu H; Shibata Y; Yamawaki F; Onozawa M; Ishida S
BMC Ophthalmol; 2020 Mar; 20(1):94. PubMed ID: 32156266
[TBL] [Abstract][Full Text] [Related]
15. Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.
AlBloushi AF; Herbort CP; Abu El-Asrar AM
Int Ophthalmol; 2021 Dec; 41(12):4187-4195. PubMed ID: 34346004
[TBL] [Abstract][Full Text] [Related]
16. [Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma].
Mihailovic N; Dyballa J; Herz S; Fluck M; Alnawaiseh M; Merté RL; Eter N
Ophthalmologe; 2020 May; 117(5):467-471. PubMed ID: 31489479
[TBL] [Abstract][Full Text] [Related]
17. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
18. NIVOLUMAB-INDUCED HARADA-LIKE UVEITIS WITH BACILLARY DETACHMENT MIMICKING CHOROIDAL METASTASIS.
Ng CC; Ng JC; Johnson RN; McDonald HR; Agarwal A
Retin Cases Brief Rep; 2023 May; 17(3):233-238. PubMed ID: 34027908
[TBL] [Abstract][Full Text] [Related]
19. Choroidal excavation in vogt-koyanagi-harada disease.
Hashida N; Fok A; Nishida K
Case Rep Ophthalmol; 2014 May; 5(2):222-5. PubMed ID: 25202266
[TBL] [Abstract][Full Text] [Related]
20. [A case of the Vogt-Koyanagi-Harada syndrome].
Peyresblanques J; Saint Val C; Collin JP
Bull Soc Ophtalmol Fr; 1984; 84(6-7):827-30. PubMed ID: 6534621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
